Cynthia Leclair-Maertens

Cynthia LeClair-Maertens is a seasoned professional in the field of clinical operations and research, currently serving as the Director of Clinical Operations at Vergent Bioscience since April 2024. Previously, Cynthia held the position of Senior Clinical Study Lead at iTeos Therapeutics and Senior Clinical Project Manager at Epizyme. With extensive experience gained from roles at Clinlogix, LeClair-Maertens LLC, IQVIA, Boston Scientific, and Medtronic, Cynthia has developed a strong background in managing clinical studies and projects. Academic credentials include a Master's degree in Cell/Cellular and Molecular Biology from Rutgers University and a Bachelor's degree in Biology from the University of Vermont, complemented by research experience in gene therapy and antibiotic drug discovery.